<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34994305</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dissemination and genome analysis of high-level ceftriaxone-resistant <i>penA</i> 60.001 <i>Neisseria gonorrhoeae</i> strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019.</ArticleTitle>
        <Pagination>
          <StartPage>344</StartPage>
          <EndPage>350</EndPage>
          <MedlinePgn>344-350</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2021.2011618</ELocationID>
        <Abstract>
          <AbstractText><b>Background:</b> After <i>Neisseria gonorrhoeae</i> FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. <b>Objectives:</b> To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant <i>penA</i> 60.001 isolates. <b>Methods:</b> The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. <i>N. gonorrhoeae</i> multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and <i>N.gonorrhoeae</i> sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. <b>Results:</b> Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing <i>penA</i> 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the <i>porB</i> gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "<i>penA</i>" and "<i>blaTEM-1B</i>". Half of <i>penA</i> 60.001 strains were fully mixed with global FC428-related strains. <b>Conclusions:</b> Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Xiaomian</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-7780-0458</Identifier>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Wentao</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Qinghui</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Yuqi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liao</LastName>
            <ForeName>Yiwen</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Zhanjin</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Xiaolin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xingzhong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Sanmei</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Heping</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>5E8K9I0O4U</RegistryNumber>
          <NameOfSubstance UI="D002939">Ciprofloxacin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>75J73V1629</RegistryNumber>
          <NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>83905-01-5</RegistryNumber>
          <NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>93AKI1U6QF</RegistryNumber>
          <NameOfSubstance UI="D000198">Spectinomycin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002939" MajorTopicYN="N">Ciprofloxacin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006069" MajorTopicYN="N">Gonorrhea</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058885" MajorTopicYN="N">Multilocus Sequence Typing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000198" MajorTopicYN="N">Spectinomycin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">N. gonorrhoeae</Keyword>
        <Keyword MajorTopicYN="N">ceftriaxone-resistant</Keyword>
        <Keyword MajorTopicYN="N">epidemiological investigation</Keyword>
        <Keyword MajorTopicYN="N">penA 60.001</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>7</Day>
          <Hour>8</Hour>
          <Minute>44</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34994305</ArticleId>
        <ArticleId IdType="pmc">PMC8794061</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2021.2011618</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rowley J, Vander Hoorn S, Korenromp E, et al. . 
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6653813</ArticleId>
            <ArticleId IdType="pubmed">31384073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tacconelli E, Carrara E, Savoldi A, et al. . 
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29276051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohnishi M, Golparian D, Shimuta K, et al. . 
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55(7):3538–3545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3122416</ArticleId>
            <ArticleId IdType="pubmed">21576437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin EY, Adamson PC, Klausner JD, et al. . 
And Vaccine development for antimicrobial-resistant Neisseria gonorrhoeae: Current strategies and future directions. Drugs. 2021;81(10):1153–1169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8182353</ArticleId>
            <ArticleId IdType="pubmed">34097283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen SC, Han Y, Yuan LF, et al. . 
Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerg Infect Dis. 2019;25(7):1427–1429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6590750</ArticleId>
            <ArticleId IdType="pubmed">30900979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiu L, Yuan Q, Li Y, et al. . 
Emergence of ceftriaxone-resistant Neisseria gonorrhoeae strains harbouring a novel mosaic penA gene in China. J Antimicrob Chemother. 2020;75(4):907–910.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31899504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Wang Y, Yong G, et al. . 
Emergence and genomic characterization of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in chengdu, China. J Antimicrob Chemother. 2020;75(9):2495–2498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32363389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan J, Chen Y, Yang F, et al. . 
High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in hangzhou, China. J Antimicrob Chemother. 2021;76(4):936–939.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33406237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin X, Zhao Y, Chen W, et al. . 
Changing antimicrobial susceptibility and molecular characterisation of Neisseria gonorrhoeae isolates in guangdong, China: in a background of rapidly rising epidemic. Int J Antimicrob Agents. 2019;54(6):757–765.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8179728</ArticleId>
            <ArticleId IdType="pubmed">31425792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas JC, Joseph SJ, Cartee JC, et al. . 
Phylogenomic analysis reveals persistence of gonococcal strains with reduced-susceptibility to extended-spectrum cephalosporins and mosaic penA-34. Nat Commun. 2021;12(1):3801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8217231</ArticleId>
            <ArticleId IdType="pubmed">34155204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Croucher NJ, Page AJ, Connor TR, et al. . 
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using gubbins. Nucleic Acids Res. 2015;43(3):e15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4330336</ArticleId>
            <ArticleId IdType="pubmed">25414349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Page AJ, Taylor B, Delaney AJ, et al. . 
SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments. Microb Genom. 2016;2(4):e000056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5320690</ArticleId>
            <ArticleId IdType="pubmed">28348851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kozlov AM, Darriba D, Flouri T, et al. . 
RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics. 2019;35(21):4453–4455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6821337</ArticleId>
            <ArticleId IdType="pubmed">31070718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darriba D, Posada D, Kozlov AM, et al. . 
ModelTest-NG: A New and scalable tool for the selection of DNA and protein evolutionary models. Mol Biol Evol. 2020;37(1):291–294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6984357</ArticleId>
            <ArticleId IdType="pubmed">31432070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Seifert HS, Hook EW, et al. . 
Gonorrhoea. Nat Rev Dis Primers. 2019;5(1):79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31754194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sánchez-Busó L, Yeats CA, Taylor B, et al. . 
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at pathogenwatch. Genome Med. 2021;13(1):61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8054416</ArticleId>
            <ArticleId IdType="pubmed">33875000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin YP, Han Y, Dai XQ, et al. . 
Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018;15(2):e1002499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5800545</ArticleId>
            <ArticleId IdType="pubmed">29408881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>St Cyr S, Barbee L, Workowski KA, et al. . 
Update to CDC's treatment guidelines for gonococcal infection, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1911–1916.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7745960</ArticleId>
            <ArticleId IdType="pubmed">33332296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Ross J, Serwin AB, et al. . 
European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2020;2020:956462420949126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33121366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ropp PA, Hu M, Olesky M, et al. . 
Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2002;46(3):769–777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC127492</ArticleId>
            <ArticleId IdType="pubmed">11850260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaskolskiy B, Dementieva E, Kandinov I, et al. . 
Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in russia, 2015-2017. PLoS One. 2019;14(7):e0220339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6657886</ArticleId>
            <ArticleId IdType="pubmed">31344102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drlica K.
Mechanism of fluoroquinolone action. Curr Opin Microbiol. 1999;2(5):504–508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10508721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh A, Tomberg J, Nicholas RA, et al. . 
Recognition of the β-lactam carboxylate triggers acylation of Neisseria gonorrhoeae penicillin-binding protein 2. J Biol Chem. 2019;294(38):14020–14032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6755799</ArticleId>
            <ArticleId IdType="pubmed">31362987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen SC, Yuan LF, Zhu XY, et al. . 
Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. J Antimicrob Chemother. 2020;75(9):2499–2502.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32473014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen XS.
Proceedings of the 2017 International Forum on Gonococcal Infections and Resistance in shenzhen, China. Sex Transm Dis. 2018;45(10):e75–e79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6759053</ArticleId>
            <ArticleId IdType="pubmed">29664765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu HJ, Seib KL, Srikhanta YN, et al. . 
Perr controls Mn-dependent resistance to oxidative stress in Neisseria gonorrhoeae. Mol Microbiol. 2006;60(2):401–416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16573689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohneck EA, Zalucki YM, Johnson PJ, et al. . 
A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. mBio. 2011;2(5):e00187–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3175627</ArticleId>
            <ArticleId IdType="pubmed">21933917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudel T, Facius D, Barten R, et al. . 
Role of pili and the phase-variable PilC protein in natural competence for transformation of Neisseria gonorrhoeae. Proc Natl Acad Sci U S A. 1995;92(17):7986–7990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC41271</ArticleId>
            <ArticleId IdType="pubmed">7644525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russell MA, Darzins A.. 
The pilE gene product of pseudomonas aeruginosa, required for pilus biogenesis, shares amino acid sequence identity with the N-termini of type 4 prepilin proteins. Mol Microbiol. 1994;13(6):973–985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7854130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong Z, Lai W, Liu M, et al. . 
Novel genes related to ceftriaxone resistance found among ceftriaxone-resistant Neisseria gonorrhoeae strains selected In vitro. Antimicrob Agents Chemother. 2016;60(4):2043–2051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4808169</ArticleId>
            <ArticleId IdType="pubmed">26787702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Criss AK, Katz BZ, Seifert HS.. 
Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes. Cell Microbiol. 2009;11(7):1074–1087.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2771623</ArticleId>
            <ArticleId IdType="pubmed">19290914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baarda BI, Zielke RA, Holm AK, et al. . 
Comprehensive bioinformatic assessments of the variability of Neisseria gonorrhoeae Vaccine candidates. mSphere. 2021;6(1):e00977–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7860988</ArticleId>
            <ArticleId IdType="pubmed">33536323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noinaj N, Buchanan SK, Cornelissen CN.. 
The transferrin-iron import system from pathogenic Neisseria species. Mol Microbiol. 2012;86(2):246–257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3468669</ArticleId>
            <ArticleId IdType="pubmed">22957710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jean S, Juneau RA, Criss AK, et al. . 
Neisseria gonorrhoeae evades calprotectin-mediated nutritional immunity and survives neutrophil extracellular traps by production of TdfH. Infect Immun. 2016;84(10):2982–2994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5038063</ArticleId>
            <ArticleId IdType="pubmed">27481245</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
